doc. MUDr. Ondřej Havránek, Ph.D.
After finishing my PhD in 2011, I worked more than six years full-time in B-cell lymphoma research at the Department of Lymphoma and Myeloma of the UT MD Anderson Cancer Center. Initially as a postdoctoral fellow and then as a research faculty (instructor). During those years, I learned many advanced and cutting-edge research methods (e.g. super resolution microscopy or genomics applications) and developed other techniques (applications of CRISPR/Cas9 for targeted genomic modifications or flow cytometry based FRET detection and calculation).
It was a tremendous experience being involved in top lymphoma research that allowed me to grow in all aspects necessary for research, both professionally and personally, and my research on B-cell receptor signaling in lymphoma was recognized by selection for multiple oral presentations (e.g. American Society of Hematology Annual Meeting 2014, 2015, and 2016) and awards and recently featured on the cover of Blood. During the last year, I decided that I would like to use my research abilities and knowledge of its clinical relevance to establish my own independent research group in lymphoma biology, and I am grateful that I got the opportunity to start my own research group at the BIOCEV institute in January 2018. I am looking forward to address unresolved issues in lymphoma specific B-cell receptor and AKT signaling and investigate other novel ideas. At the same time, I will continue several projects in close collaboration with my former supervisor and other faculty members at the MD Anderson Cancer Center.
More information about my lab - HERE